Logo
Secure Registration

International Conference on Medicinal Chemistry and Pharmacogenomics

ICMCPG

15th Mar – 16th Mar 2027 Vienna, Austria

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 12
01 Advancements in Medicinal Chemistry +
This track will explore the latest breakthroughs in medicinal chemistry, focusing on novel compounds and their therapeutic potentials. Participants will discuss innovative synthetic methods and their implications for drug discovery.
SDG 3 SDG 9
02 Pharmacogenomics and Personalized Medicine +
This session aims to highlight the role of pharmacogenomics in tailoring drug therapies to individual genetic profiles. Presentations will cover recent findings that enhance our understanding of drug response variability among patients.
SDG 3 SDG 4
03 Molecular Modeling in Drug Design +
This track will delve into the applications of molecular modeling techniques in the rational design of new therapeutic agents. Discussions will include computational approaches that facilitate the prediction of drug interactions and efficacy.
SDG 3 SDG 9
04 Chemical Biology Approaches in Therapeutics +
This session will focus on the intersection of chemical biology and medicinal chemistry, emphasizing how chemical tools can elucidate biological processes. Researchers will present case studies demonstrating the impact of these approaches on drug development.
SDG 3 SDG 4
05 Innovations in Synthetic Methods +
This track will showcase cutting-edge synthetic methodologies that enhance the efficiency and selectivity of drug synthesis. Participants will discuss the implications of these innovations for the pharmaceutical industry.
SDG 9 SDG 12
06 Translational Research in Medicinal Chemistry +
This session will address the challenges and successes in translating laboratory findings into clinical applications. Emphasis will be placed on collaborative efforts between chemists and clinicians to bridge the gap between research and practice.
SDG 3 SDG 9
07 Laboratory Techniques in Drug Discovery +
This track will cover essential laboratory techniques that are pivotal in the drug discovery process. Presentations will include high-throughput screening, structure-activity relationship studies, and other methodologies that drive innovation.
SDG 3 SDG 9
08 Therapeutic Innovations in Oncology +
This session will focus on the development of novel therapeutic agents for cancer treatment, highlighting recent advancements in targeted therapies and immunotherapy. Experts will discuss the role of medicinal chemistry in overcoming resistance mechanisms.
SDG 3 SDG 9
09 Pharmacology and Drug Mechanisms +
This track will explore the pharmacological aspects of drug action, including mechanisms of action, pharmacokinetics, and pharmacodynamics. Participants will present research that elucidates the relationship between chemical structure and biological activity.
SDG 3 SDG 9
10 Natural Products in Medicinal Chemistry +
This session will highlight the significance of natural products as a source of novel therapeutic agents. Discussions will include the isolation, characterization, and modification of bioactive compounds derived from natural sources.
SDG 3 SDG 15
11 Regulatory Challenges in Drug Development +
This track will address the regulatory landscape surrounding drug development, focusing on the challenges faced by researchers and companies. Participants will discuss strategies to navigate regulatory requirements while ensuring safety and efficacy.
SDG 3 SDG 16